Neurocrine Biosciences (NBIX) Exchange Rate Effect (2023 - 2025)
Neurocrine Biosciences (NBIX) reported Exchange Rate Effect of -$200000.0 for Q3 2025, down 166.67% on a YoY basis from $300000.0 in Q3 2024, and up 33.33% quarter-over-quarter from -$300000.0 in Q4 2024.
Neurocrine Biosciences (NBIX) Exchange Rate Effect (2023 - 2025) Analysis & Trends
Neurocrine Biosciences has reported Exchange Rate Effect for 3 years, with the latest figure at -$200000.0 in Q3 2025.
- For the quarter ending Q3 2025, Exchange Rate Effect fell 166.67% year-over-year to -$200000.0; the trailing twelve-month figure through Dec 2025 stood at -$200000.0 (changed N/A YoY), and the FY2023 full-year result was $300000.0, up 123.08% from the prior year.
- Exchange Rate Effect for Q3 2025 stood at -$200000.0, up from -$300000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $300000.0 in Q4 2023, with the low at -$300000.0 in Q4 2024.
- Historically, Exchange Rate Effect has averaged $25000.0 across 3 years, with a median of $50000.0 in 2023.
- Annual changes were most pronounced in 2024 — Exchange Rate Effect sank 200.0% — and 2025, when it plunged 166.67%.
- Neurocrine Biosciences' Exchange Rate Effect stood at $300000.0 in 2023, then slumped by 200.0% to -$300000.0 in 2024, then jumped by 33.33% to -$200000.0 in 2025.
- The last three Exchange Rate Effect figures came in at -$200000.0 (Q3 2025), -$300000.0 (Q4 2024), and $300000.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FX Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -17.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 17.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -5.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -22,000.00 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -2.38 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -200,000.00 |
| Sep 30, 2025 | -200,000.00 |
| Dec 31, 2024 | -300,000.00 |
| Dec 31, 2024 | -300,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Dec 31, 2023 | 300,000.00 |
| Dec 31, 2023 | 300,000.00 |